Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain

Overview of attention for article published in BMC Pulmonary Medicine, February 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 6 X users

reddit: 1 Redditor

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 21 Mendeley

Summary X Reddit Dimensions citations

So far, Dimensions has found 1 citation of this research output.

1

The most recent citing publication is shown below. View this citation on Dimensions.

Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1

Article in Journal of Medical Economics (March 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.